L.M. ANTSILEVICH, L.A. YAGUDINA

Kazan State Medical Academy, 49 Butlerova St., Kazan, Russian Federation 420012

Antsilevich L.M. — Cand. Sc. Biology, Associate Professor of the Department of Clinical Pathology, tel. (843) 236-09-09, e-mail: yagudinaleila@mail.ru

Yagudina L.A. — Candidate of Medical Science, Associate Professor of the Department of Clinical Pathology, tel. (843) 236-09-09, e-mail: yagudinaleila@mail.ru

The article explains the possibilities of modern serological method of research — enzyme immunoassay — in the diagnosis of infectious, endocrine and oncological diseases. Were examined the practical examples of individual diagnosis of pathological conditions, factors affecting the result, the diagnostic value of the markers used.

Key words: enzyme immunoassay, antigen, antibody.

 

REFERENCES

1. Belaya O.F., Pak S.G. Ways of improving laboratory diagnosis of infectious diseases. Vestnik RAMN, 2010, no. 11, pp. 50-53 (in Russ.).

2. Dolgov V.V., Rakova N.G., Kolupaev V.E., Rytikova N.S. Immunofermentnyy analiz v kliniko-diagnosticheskikh laboratoriyakh [Immunosorbent assay in clinical diagnostic laboratories]. Moscow-Tver: Triada, 2007. 320 p.

3. Kishkun A.A. Immunologicheskie issledovaniya i metody diagnostiki infektsionnykh zabolevaniy v klinicheskoy praktike [Immunological studies and methods of diagnosis of infectious diseases in clinical practice]. Meditsinskoe informatsionnoe agentstvo, 2009.

4. Samoylenkov P.V. Printsipy immunofermentnogo analiza, osnovnye vidy IFA, primenenie v diagnostike [Immunoassay principles, the main types of ELISA application in diagnostics]. Moscow, 2009, RGMU.

5. Gan S.D., Patel K.R. Enzyme immunoassay and enzyme-linked immunosorbent assay. J. Invest Dermatol., 2013, Sept., vol. 133 (9), p. 12.

6. Malashenkova I.K., Didkovskiy N.A. et al. Clinical forms of chronic Epstein — Barr virus infection : diagnosis and treatment. Infektsionnye bolezni, 2010 (in Russ.), available at: MedLiks.ru.

7. Bennet N.J. et al. Mononucleosis and Epstein-Barr infection, 2009, available at: Medscape.com.

8. Dolcetti R., Martorelli E. et al. The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorder. Haematologica, 2010, Oct, vol. 95 (10), pp. 2237-9.

9. Maakaround N.R., Moanna A. et al. Viral infections associated with haemophagocytic syndrome. Rev. Med. Virol., 2010, March, vol. 20 (2), pp. 93-105.

10. Grandien M., Olding-Stenkvist E. Rapid viral diagnosis — a modern technic for the early diagnosis of virus infections. Lakartidningen, 1984, March 28, vol. 81 (13), pp. 1277-84.

11. Kishkun A.A. Immunologicheskie issledovaniya i metody diagnostiki infektsionnykh zabolevaniy v klinicheskoy praktike [Immunological studies and methods of diagnosis of infectious diseases in clinical practice]. Meditsinskoe informatsionnoe agentstvo, 2009. 744 p.

12. Kishkun A.A. Sovremennye tekhnologii povysheniya kachestva klinicheskoy laboratornoy diagnostiki [Modern technology to improve the quality of clinical laboratory diagnostics]. Moscow: RAMLD, 2005.

13. Nechaev V.N. Laboratory diagnosis of thyroid diseases. Spravochnik zaveduyushchego. KDL, 2010, no. 6 (in Russ.).

14. Dolgov V.V., Shabalova I.P., Gitel’ E.P. Laboratornaya diagnostika zabolevaniy shchitovidnoy zhelezy [Laboratory diagnosis of thyroid diseases]. Moscow: Triada, 2002.

15. Dedov I.I. Diagnostika zabolevaniy shchitovidnoy zhelezy [Diagnosis of diseases of the thyroid gland]. Moscow: Vidar-M, 2013.

16. Dedov I.I., Mel’nichenko G.A., Pronin V. Klinika i diagnostika endokrinnykh narusheniy [Clinic and diagnosis of endocrine disorders]. Moscow: Triada, 2006.

17. Dedov I.I., Peterkova V.A. Detskaya endokrinologiya: Rukovodstvo dlya vrachey [Pediatric endocrinology: a guide for physicians]. Moscow, 2008.

18. Taylor P.N., Razvi S. et al. Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range. J. Clinic. Endocrinol. Metab., 2013, Sept., vol. 98 (9), pp. 3562-71.

19. Barbesino G., Tomer I. Clinical review: Clinical utility of TSH receptor antibodies. J. Clinic. Endocrinol. Metab., 2013, June, vol. 98 (6), pp. 2247-55.

20. Nakajima Y., Yamada M. Subclinical thyroid disease. Nihon Rinsho, 2012, Nov., vol. 70 (11), pp. 1865-1871.

21. Bergmann P., Cannie M. Blood tests and imaging in thyroid pathology. Rev. Med. Brux., 2012, Sept., vol. 33 (4), pp. 246-53.

22. Corvilain B. Subclinical hyperthyroidism: from diagnosis to treatment. Rev. Med. Brux., 2012, Sept., vol. 33 (4), pp. 241-5.

23. Gessl A., Lemmens-Gruber R. et al. Thyroid disorders. Handb. Exp. Pharmacol., 2012, vol. (214), pp. 361-86.

24. Gershteyn E.S., Ovchinnikova L.K., Tereshkina I.V., Digaeva M.A., Tuleulova A.A. Laboratory and clinical research perspectives of molecular tumor markers. Voprosy biologicheskoy, meditsinskoy i farmatsevticheskoy khimii, 2010, no. 4 (in Russ.).

25. Kery K.C., Cooperberg M.R, Biomarkers in prostate cancer surveillance and screening: past, present and future. Ther Adv. Urol., 2013, Dec., vol. 5 (6), pp. 318-29.

26. Romero Otero J., Garcia Gomez B. et al. Prostate cancer biomarkers: an update. Urol. Oncol., 2014, Febr 1, pp. 397-9.

27. Roumeguere T., Van Velthoven R. Focus on the screening for prostate cancer by PSA. Rev. Med. Brux., 2013, Sept., vol. 34 (4), pp. 311-9.

28. Crawford E.D., Bennet C.L. et al. The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int., 2013, Sept., vol. 112 (5), pp. 548-60.

29. Tel’nova E.A., Bondarev S.V. et al. Evaluation of health cost-effectiveness of laboratory tests for tumor markers in conducting additional clinical examination Citizens in Russia. Vestnik Roszdravnadzora, 2010, no. 5, pp. 46-53 (in Russ.).

30. Bakhlaev I.E., Yastrebova A.V. et al. Evaluation of tumor markers in patients with colorectal cancer. Onkokhirurgiya, 2012, vol. 4, no. 2, p. 22 (in Russ.).

31. Kurynin R.M. Achievements national molecular genetics to clinical oncourology. Urologiya segodnya, 2009, no. 4, p. 17 (in Russ.).

32. Egorova N.M., Matylevich O.P. et al. The role of some tumor markers in predicting recurrence and metastasis in patients with cervical cancer. Onkologicheskiy zhurnal, 2011, vol. 5, no. 3, p. 58 (in Russ.).